U74389G prevents vasospasm after subarachnoid hemorrhage in dogs

Neurosurgery

Volumn 42, Issue 6, 1998, Pages 1339-1346

  Macdonald, R Loch ^a   Bassiouny, Mohammed ^a   Johns, Lydia ^a   Sajdak, Michael ^a   Marton, Linda S ^a   Weir, Bryce K ^a   Hall, Edward D ^b   Andrus, Paula K ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Free radical; Lipid peroxidation; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; GENTISIC ACID; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD CLOT; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTIOXIDANTS; CEREBRAL ANGIOGRAPHY; DOGS; HYDROXYBENZOIC ACIDS; ISCHEMIC ATTACK, TRANSIENT; MALONDIALDEHYDE; PREGNATRIENES; SUBARACHNOID HEMORRHAGE;

EID: 0031748272     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199806000-00089     Document Type: Article

References (42)

1. Althaus JS, Andrus PK, Williams CM, Von Voightlander PF, Cazers AR, Hall ED: The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury: Reversal by tirilazad mesylate (U-74006F). Mol Chem Neuropathol 20:147-162, 1993.
2. Asano T, Sasaki T, Koide T, Takaur K, Sano K: Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res 6:49-53, 1984.
3. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T: Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792-803, 1996.
4. Audus KL, Guillot FL, Braughler JM: Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radic Biol Med 11:361-371, 1991.
5. Bharadwaj LA, Prasad K: Mechanism of hydroxyl radical-induced modulation of vascular tone. Free Radic Biol Med 22:381-390, 1997.
6. Boisvert DPJ, Schreiber C: Interrelationship of excitotoxic and free radical mechanisms, in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenhaftliche Verlag, 1992, pp 1-10.
7. Cini M, Moeretti A: Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol Aging 16:53-57, 1995.
8. Esterbauer H, Lang J, Zadravec S, Slater TF: Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 105:319-323, 1984.
9. Everse J, Hsia N: The toxicities of native and modified hemoglobins. Free Radic Biol Med 22:1075-1099, 1997.
10. Fici GJ, Althaus JS, Von Voightlander PF: Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity. Free Radic Biol Med 22:223-228, 1997.
11. Floyd RA, Watson JJ, Wong PK: Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylanon products. J Biochem Biophys Methods 10:221-235, 1984.
12. Gaetani P, Marzatico F, Lombardi D, Adinolfi D, Rodriguez y Baena R: Effect of high-dose methylprednisolone and U74006F on eicosanoid synthesis after subarachnoid hemorrhage in rats. Stroke 22:215-220, 1991.
13. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage: A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995.
14. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86: 467-174, 1997.
15. Hall FD, Andrus PK, Yonkers PA: Brain hydroxvl radical generation in acute experimental head injury. J Neurochem 60:588-594, 1993.
16. Hall FD, McCall JM, Means FD: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28:221-268, 1994.
17. Harada T, Mayberg MR: Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J Neurosurg 77:763-767, 1992.
18. Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A: Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 78:592-597, 1993.
19. Kanamaru K, Weir BKA, Findlay JM, Grace M, Macdonald RL: A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model. Neurosurgery 27:29-38, 1990.
20. Kanamaru K, Weir BKA, Simpson I, Witbeck T, Grace M: Effect of 21-aminosteroid U-74006F on lipid peroxidarion in subarachnoid clot. J Neurosurg 74:454-459, 1991.
21. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996.
22. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery: Part 1 - Overall management results. J Neurosurg 73:18-36, 1990.
23. Kasuya H, Weir BKA, Nakane M, Pollock JS, Johns L, Marton LS, Stefansson K: Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82:250-255, 1995.
24. Kwon TW, Watts BM: Determination of malonaldehyde by ultraviolet spectrophotometry. J Food Sci 28:627-630, 1963.
25. Laizure SC, Franklin LK, Kaiser DG, Williams CL, Stevens RC, Sanders PL, Miller M: Disposition of tirilazad (L74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat. Drug Metab Dispos 21:951-954, 1993.
26. Macdonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
27. Macdonald RL, Weir BK: Cerebral vasospasm and free radicals. Free Radic Biol Med 16:633-643, 1994.
28. Martinez MC, Bosch-Morell F, Raya A, Roma J, Aldasoro M, Vila I, Lluch S, Romero FJ: 4-Hydroxynonenal, a lipid peroxidarion product, induces relaxation of human cerebral arteries. J Cereb Blood Flow Metab 14:693-696, 1994.
29. Mathews WR, Marshcke CK Jr, McKenna R: Tirilazad mesylate protects endothelium from damage by reactive oxygen. J Mol Cell Cardiol 24[Suppl III]:S17, 1992 (abstr).
30. Matsui T, Asano T: Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurgery 34:1035-1039, 1994.
31. Polidori MC, Frei B, Rordorf C, Ogilvy CS, Koroshetz WJ, Beal MF: Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage. Free Radic Biol Med 23:762-767, 1997.
32. Sasaki T, Asano T, Sano K: Cerebral vasospasm and free radical reactions. Neurol Med Chir (Tokyo) 20:145-153, 1980.
33. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K: The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery: An experimental study on cerebral vasospasm. J Neurosurg 54:357-365, 1981.
34. Shi F, Cavitt J, Audus KL: 21-aminosteroid and 2-(aminomethyl)-chromans inhibition of arachidonic acid-induced lipid peroxidarion and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radic Biol Med 19:349-357, 1995.
35. Siesjö BK, Agardh CD, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1:165-211, 1990.
36. Smith SL, Scherch HM, Hall ED: Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. J Neurosurg 84:229-233, 1996.
37. Steinke DE, Weir BKA, Findlay JM, Tanabe T, Grace M, Krushelnycky BW: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-186, 1989.
38. Takahashi S, Kassell NF, Toshima M, Dougherty DA, Foley PL, Lee KS: Effect of U88999E on experimental cerebral vasospasm in rabbits. Neurosurgery 32:281-288, 1993.
39. G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke 24:1584-1589, 1993.
40. Vollmer DG, Hongo K, Ogawa H, Tsukahara T, Kassell NF: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:27-32, 1991.
41. Vollmer DG, Kassell NF, Hongo K, Ogawa H, Tsukahara T: Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol 31:190-194, 1989.
42. Zuccarello M, Marsch JT, Schmitt G, Woodward J, Anderson DK: Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 71:98-104, 1989.